ID: ALA5286829

Max Phase: Preclinical

Molecular Formula: C19H17FN2O3S

Molecular Weight: 372.42

Representations

Canonical SMILES:  Cc1cn(-c2cccc(F)c2)c2ccc(C(=O)NS(=O)(=O)C3CC3)cc12

Standard InChI:  InChI=1S/C19H17FN2O3S/c1-12-11-22(15-4-2-3-14(20)10-15)18-8-5-13(9-17(12)18)19(23)21-26(24,25)16-6-7-16/h2-5,8-11,16H,6-7H2,1H3,(H,21,23)

Standard InChI Key:  LLHOCWOJQNGDRO-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 372.42

Molecular Weight (Monoisotopic): 372.0944

AlogP: 3.30

#Rotatable Bonds: 4

Polar Surface Area: 68.17

Molecular Species: ACID

HBA: 4

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 4.07

CX Basic pKa:

CX LogP: 3.71

CX LogD: 2.77

Aromatic Rings: 3

Heavy Atoms: 26

QED Weighted: 0.76

Np Likeness Score: -1.56

References

1. Karanjule N, Hayashi N, Suzuki S, Tsuda T, Tokumaru E, Tanaka K, Kimoto H, Domon Y, Takahashi S, Kubota K, Kitano Y, Yokoyama T, Koishi R, Fujiwara C, Inaba S, Asano D, Sakakura T, Takasuna K, Shinozuka T..  (2023)  N-Aryl Indoles as a Novel Class of Potent Na_V1.7 Inhibitors.,  14  (6): [PMID:37312847] [10.1021/acsmedchemlett.3c00079]

Source

Source(1):

• Scientific Literature